Notably, the low gene expression of SLCO1B1 and SLCO2B1 are correlated significantly with a shorter overall survival in HCC patients, with a log-rank p-value of 0.005 and 0.002, respectively. Here, SLCO2B1 is linked to hepatocellular carcinoma.